Thrombocytopenic purpura can develop from an induced antibody response that destroys platelets. Megakaryocyte production may also play a role. Although the inciting antigen is usually not identified, it is important to consider medications. This article presents the case of a man who developed sudden onset of severe thrombocytopenia associated with the ingestion of quinine-containing tonic water.
If any of these few notes on the eff ects of quinine prove of any use to the profession, or add one drop to the ocean of science, the purpose of the writer will be fully answered. -W. H. Vipan, 1865 (1) Th rombocytopenic purpura can be life threatening with severe complications when platelet counts fall below 25,000/ uL. Treatment is directed at suppressing or eliminating the antibody response that destroys the platelets and/or the stimulus that impacts the production of platelets by megakaryocytes. Medications have been implicated in the aberrant antibody response and, in those cases, their identifi cation is important in treatment and prevention of future episodes. Th e patient discussed herein developed a sudden and dramatic decline in peripheral platelet counts, possibly related to the consumption of tonic water.
CASE PRESENTATION
A 70-year-old man presented with a 2-day history of nosebleeds, mucosal bleeding, painful bruising of his tongue, and diff use ecchymoses over his arms, legs, and trunk (Figure 1) . Th e previous week he had been seen for a routine checkup. At the time, he felt well, had a platelet count of 151,000/uL, a hemoglobin of 14.1 g/dL, a hematocrit of 42.3%, and no bleeding manifestations. In only 3 days, he developed diff use bleeding, and his platelet count had dropped to 1000/uL. He was admitted to the hospital. During the 2 days prior to presentation, he had been celebrating with a friend, drinking beverages containing tonic water.
His estimated consumption of the tonic water alone was up to 80 ounces over 2 days. He had indulged in tonic water beverages previously and on a regular basis, though in more moderate quantities. He had a previous history of atrial fi brillation, hypertension, and hyperlipidemia. At age 67, he had replacement of his stenotic aortic valve by a bioprosthesis. Th ere had been no antecedent infectious illnesses. He had stopped warfarin before admission due to the bleeding. Other medications included pravastatin, carvedilol, digoxin, quinapril, vitamin D, montelukast, and fl uticasone.
On examination, the patient had diff use bleeding into his buccal mucosa and posterior pharynx. His tongue was swollen, tender, and bruised. Petechiae and ecchymoses were present over his arms, legs, and trunk. Th e nasal mucosa was ecchymotic, with dried dark blood. Th e feces were melanotic and the fecal immunochemical test was positive. Laboratory results are shown in the Table. A peripheral blood smear demonstrated only sparse platelets (Figure 2 ), and bone marrow biopsy showed megakaryocytes, which were predominantly mature with focally increased cellularity (Figure 3 ). Flow cytometry showed no evidence of hematopoietic neoplasia, lymphoproliferative disease, or plasma cell dyscrasia.
Th e patient was treated with dexamethasone 40 mg daily for 4 days. His platelet count promptly rose. His bleeding resolved and ecchymoses subsided by the fourth day of admission, when he was discharged. His platelet count at discharge was 67,000/ uL and was back in the normal range shortly thereafter. He has since resumed his previous medications, avoided tonic water, and has had no further episodes of thrombocytopenia.
DISCUSSION
Immune thrombocytopenia is defi ned as a platelet count of <100,000/uL with no evidence of leukopenia or anemia. Th e condition has been referred to as "idiopathic" but is more frequently called "immune" thrombocytopenic purpura (ITP), even though aspects of the pathogenesis are not always understood. Primary ITP is defi ned as cases with no clear underlying causation. Secondary ITP is the label affi xed when a medication, infection, or other condition accounts for the abnormal Immune thrombocytopenia associated with consumption of tonic water F. David Winter Jr., MD, MSc antibody response (2) . Various secondary causes of immune thrombocytopenia are listed in Table 2 .
A positive test for antibodies would have made for a more convincing diagnosis, although it is known that the absence of such results cannot rule out a diagnosis of drug-induced immune thrombocytopenia (3). Th ere had been a several-week delay in testing for these antibodies, which could have been a factor in the negative report. In addition, problems exist with standardization of testing. Antiplatelet antibodies are known to have low sensitivity and low specifi city (4) . Th e ability of laboratories to correctly identify the antibodies has been estimated to be in the range of 20% to 97% (5).
Th e low haptoglobin level in this patient suggests the possibility of hemolysis, although no signifi cant schistocytes were seen on the peripheral blood smear (Figure 2) . Th e drop in hemoglobin was likely due to gastrointestinal blood loss implied by the positive fecal immunochemical test. Hemolytic uremic syndrome has been reported with quinine ingestion (6), although the absence of proteinuria, normal creatinine, and convincing hemolysis makes this diagnosis unlikely.
Th rombocytopenia, when it occurs due to quinine antibodies, is caused by a sensitization to quinine from prior exposure. Upon reexposure, antibodies develop to the drug or to metabolites of the drug. Importantly, and in contrast to primary ITC, platelet levels usually return to normal promptly when quinine is withdrawn. Primary "idiopathic" thrombocytopenia also behaves diff erently, with a slower onset (7) . Th e rapid onslaught of severe thrombocytopenia in this case favors an antibody response to a medication or substance for which there had been prior sensitization. Th e patient's prompt rise in platelet counts and normal platelet counts since initial treatment also favor secondary ITP.
Purpura was fi rst linked with quinine in a report on four patients in 1865 (1). Most cases today are idiopathic, but increasingly medications have been found to play a role. Quinine is reported to be one of the most frequent causes of druginduced thrombocytopenia. It is thought to be able to bind to platelet membranes and then stimulate IgG antibodies. Th e antibodies result in destruction of platelets only when the drug is present, and they go away in the absence of the drug. As mentioned above, antibodies to nondrug metabolites can also result in thrombocytopenia and should be included in testing (8) . Megakaryocytes may also bind with IgG in the presence of quinine, resulting in apoptosis, a decrease in cell viability and an increase in cell death of the precursor cells (9) .
Quinine sulfate is derived from the bark of the Cinchona tree and has been used for centuries as a prophylaxis and treatment for the malaria parasite. Quinine is dissolved in carbonated water to produce tonic water. Sweeteners such as high-fructose corn syrup are often added in contemporary preparations. Th e taste of tonic water was originally quite bitter, but was more easily tolerated when mixed with gin. A daily "gin ration" was prescribed for the offi cers of the British East India Company in the 1700s. Winston Churchill, a fan of the gin and tonic drink, once proclaimed, "Th e gin and tonic has saved more Englishmen's lives, and minds, than all the doctors in the Empire" (10) .
Other drugs were subsequently found to be more effective for malaria, but quinine has remained popular as a treatment for nocturnal leg cramps. At least one study has (11) . Others have cautioned its use for such purposes (12) . All over-the-counter products containing quinine sulfate were banned by the US Food and Drug Administration on December 12, 2006 . Th e ban included the announcement of "665 reports of adverse events with serious outcomes associated with quinine use, including 93 deaths" (13) . A prescription preparation, Qualaquin, remains available in a 324 mg tablet. However, the Food and Drug Administration warned about its use for leg cramps in 2010, stating, "Qualaquin should not be used for night time leg cramps. Qualaquin use may result in serious and lifethreatening hematological reactions" (14) . With the absence of nonprescription quinine preparations and the strong caution to physicians about prescription Qualaquin, many have resorted to quinine-containing tonic water to ease troublesome leg cramps. Th is case suggests that tonic water to treat leg cramps, or for celebration, should be used in moderate doses, if at all. 
